trending Market Intelligence /marketintelligence/en/news-insights/trending/YkwUcMlsuoUq0IkSlnRC_g2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Resverlogix closes C$87M placement with Shenzhen Hepalink

Blog

Banking Essentials Newsletter - February Edition

Blog

Message in a (Word)Cloud

Six trends shaping the industries and sectors we cover in 2021

Six trends shaping the industries and sectors we cover in 2021


Resverlogix closes C$87M placement with Shenzhen Hepalink

Resverlogix Corp. closed its private placement of 60,416,667 equity units to Shenzhen Hepalink Pharmaceutical Group Co. Ltd. priced at C$1.44 per unit for gross proceeds of C$87 million.

Each unit comprises 1 common share and 0.082759 of a common share purchase warrant. Each full warrant will be exercisable at a price of C$1.64 per share for a period of four years from the offering's closing.

The company plans to use the net proceeds to repay its C$68.8 million secured loan, which matures Dec. 26.